NO920854L - Fremgangsmaate og sammensetninger for ikke-invasiv dose til effekt-administrering av lipofile medikamenter - Google Patents

Fremgangsmaate og sammensetninger for ikke-invasiv dose til effekt-administrering av lipofile medikamenter

Info

Publication number
NO920854L
NO920854L NO92920854A NO920854A NO920854L NO 920854 L NO920854 L NO 920854L NO 92920854 A NO92920854 A NO 92920854A NO 920854 A NO920854 A NO 920854A NO 920854 L NO920854 L NO 920854L
Authority
NO
Norway
Prior art keywords
patient
lollipop
dose
compositions
lipofile
Prior art date
Application number
NO92920854A
Other languages
English (en)
Other versions
NO920854D0 (no
Inventor
Theodore Stanley
Brian Hague
Original Assignee
Univ Utah Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Utah Res Found filed Critical Univ Utah Res Found
Publication of NO920854D0 publication Critical patent/NO920854D0/no
Publication of NO920854L publication Critical patent/NO920854L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Fremgangsmåte og sammensetninger for ikke-invasiv administrering av llpofile medikamenter på en dose-tll- effekt måte for å gl antlmlgrene, oksytoklsk, antl- emetisk, hypoglycemisk, antl-Parkinson, antldiuretisk, antifungal, antlsekretorlsk eller bronkodilatorisk aktivitet. En pasient blir beroliget når han får slikkepinnen og det llpofile medikamentet går hurtig inn i pasientens blodstrøm ettersom slikkepinnen blir suget på. Under behandlingen av pasienten, kan legen observere pasientens tilstand og avslutte bruken av slikkepinnen når den ønskede effekten er oppnådd hos pasienten. Den medikamentlnneholdende slikkepinnen kan bli selvadministrert av pasienten som en respons til subjektive symptomer og til pasientens mottagelighet for det lipofile medikamentet.
NO92920854A 1989-09-05 1992-03-04 Fremgangsmaate og sammensetninger for ikke-invasiv dose til effekt-administrering av lipofile medikamenter NO920854L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/003801 WO1991003233A1 (en) 1989-09-05 1989-09-05 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs

Publications (2)

Publication Number Publication Date
NO920854D0 NO920854D0 (no) 1992-03-04
NO920854L true NO920854L (no) 1992-04-27

Family

ID=22215208

Family Applications (2)

Application Number Title Priority Date Filing Date
NO92920854A NO920854L (no) 1989-09-05 1992-03-04 Fremgangsmaate og sammensetninger for ikke-invasiv dose til effekt-administrering av lipofile medikamenter
NO92920855A NO920855L (no) 1989-09-05 1992-03-04 Medikamentinneholdende matrise

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO92920855A NO920855L (no) 1989-09-05 1992-03-04 Medikamentinneholdende matrise

Country Status (8)

Country Link
EP (1) EP0493380B1 (no)
JP (1) JP2758985B2 (no)
AT (1) ATE159658T1 (no)
AU (2) AU645966B2 (no)
DE (1) DE68928415T2 (no)
DK (1) DK175773B1 (no)
NO (2) NO920854L (no)
WO (1) WO1991003233A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH624011A5 (no) * 1977-08-05 1981-07-15 Battelle Memorial Institute
DE69635007T2 (de) * 1995-05-11 2006-06-01 University Of Utah Research Foundation, Salt Lake City Tabakersatz
US20060051413A1 (en) * 2004-09-08 2006-03-09 Chow Sing S M Method of enhancing absorptions of transmucosal administration formulations
US7776831B2 (en) * 2006-02-01 2010-08-17 Weg Stuart L Use of antifungal compositions to treat upper gastrointestinal conditions
US20160022643A1 (en) * 2014-07-22 2016-01-28 Professional Compounding Centers Of America Oral Transmucosal Compositions including Aromatase Inhibitors for Low Testosterone Levels in Men
CN106999436B (zh) 2014-10-01 2021-07-02 奥克希托恩生物科学公司 含有分娩控制物质的口服崩解固体药物剂量单元
ES2821822T3 (es) 2014-10-01 2021-04-27 Oxytone Bioscience B V Unidad de dosificación farmacéutica sólida desintegrante por vía oral que contiene una sustancia de control de partos
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
CN114206349A (zh) 2019-04-17 2022-03-18 指南针探路者有限公司 治疗神经认知障碍、慢性疼痛及减轻炎症的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2208120A (en) * 1938-03-02 1940-07-16 William B Coleman Pharmaceutical preparation and method of making same
US3943928A (en) * 1974-09-25 1976-03-16 Lariccia Anthony H Eliminating the safety hazard in oral dissolution of a solid
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
US4551329A (en) * 1984-01-20 1985-11-05 Joan Harris Oral medicament lollipop
US4671953A (en) * 1985-05-01 1987-06-09 University Of Utah Research Foundation Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics

Also Published As

Publication number Publication date
DE68928415T2 (de) 1998-02-26
DK175773B1 (da) 2005-02-14
ATE159658T1 (de) 1997-11-15
AU6069794A (en) 1994-06-23
EP0493380B1 (en) 1997-10-29
EP0493380A4 (en) 1992-10-07
EP0493380A1 (en) 1992-07-08
WO1991003233A1 (en) 1991-03-21
NO920855D0 (no) 1992-03-04
JP2758985B2 (ja) 1998-05-28
AU645966B2 (en) 1994-02-03
JPH05501854A (ja) 1993-04-08
DK30092A (da) 1992-05-05
DE68928415D1 (de) 1997-12-04
DK30092D0 (da) 1992-03-05
NO920854D0 (no) 1992-03-04
AU5035290A (en) 1991-04-08
NO920855L (no) 1992-04-10

Similar Documents

Publication Publication Date Title
Kennedy et al. Intravenous regional analgesia: an appraisal
NO924209L (no) Doseringsform for tilfoersel av et antiparkinsonmiddel
DE69003392D1 (de) Dosisform zur oralen verabreichung des hypoglykämischen glipizids.
HK18695A (en) Inhalation medicaments for treating respiratory disorders
ATE92762T1 (de) Medikamente.
JPH05504546A (ja) 痛みのある疾患又はアレルギー性疾患の治療用組成物及び治療法
US8178498B1 (en) Medicament and method of treating an organism with medicaments
NO920854D0 (no) Fremgangsmaate og sammensetninger for ikke-invasiv dose til effekt-administrering av lipofile medikamenter
MXPA02003495A (es) Derivados de piridinio para el manejo de complicaciones vasculares diabeticas y relacionadas con la edad, proceso para su preparacion, y usos terapeuticos de los mismos.
Aldrete et al. Reverse carotid blood flow—a possible explanation for some reactions to local anesthetics
Clark Marihuana and the cardiovascular system
Bloom et al. Clinical evaluation of prazosin as the sole agent for the treatment of hypertension: A double-blind cross-over study with methyldopa.
IL112288A (en) Use of riluzole in the manufacture of a medicament for the treatment of mitochondrial diseases
Sugai et al. Sequential changes in the fade of tetanic tension after the administration of tubocurarine in anaesthetized man
Hultgren et al. Clinical and experimental study of use of khellin in treatment of angina pectoris
Reynolds et al. Circulatory versus respiratory deaths from pentothal sodium
CN2233753Y (zh) 护心袋
JPS6442423A (en) Remedy containing propaphenone antipode
RU94018748A (ru) Лекарственный сбор для лечения больных с нарушениями сердечного ритма
RU2040933C1 (ru) Способ лечения гипертонической болезни
RU94019564A (ru) Способ лечения желудочно-кишечных заболеваний
Woods Sedation for dental treatment of infants. II. Clinical procedure
王小马 ELECTROIMPULSE ACUPUNCTURE TREATMENT OF 110 CASES OF ABDOMINAL PAIN AS A SEOUELA OF ABDOMINAL SURGERY
Samuels et al. Regional anesthesia for the emergency department physician
Blower Posts in clinical rheumatology